Nissay Capital

Nissay Capital, established in 1991, is a Tokyo-based venture capital firm. It specializes in providing seed, startup, growth, middle stage, and later stage capital to companies across various sectors, including information technology, manufacturing, medical, distribution, and retail. The firm manages multiple funds, with its most recent being Nissay Capital No. 9. It typically invests a minimum of JPY 1 billion per company, targeting pre-IPO investments with projected market capitalization of JPY 50 billion at IPO.

Eiji Arima

President and CEO

Junichi Imoto

Senior Venture Capitalist

Kosuke Ueda

CEO

Past deals in CMS

Medigle

Seed Round in 2025

Medigle is a consulting firm that offers medical consulting and B2B services, focusing on regional medical cooperation. The company operates a cloud-based system designed to enhance communication among healthcare providers by centralizing customer information through a customer management system. This platform facilitates digitalized communication, allowing hospitals and medical professionals to streamline their operations and concentrate on their core competencies. By fostering collaboration and improving information management, Medigle aims to support the healthcare industry's efficiency and effectiveness.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.